Total sample (N = 520) | BD P- (N = 303) | BD P + (N = 217) | Z/χ2 | P | |
---|---|---|---|---|---|
Age (Mean ± SD) a | 35.15 ± 13.22 | 35.57 ± 13.69 | 34.55 ± 12.55 | -0.59 | 0.558 |
Male (N, %) b | 252(48.46%) | 147(48.51%) | 105(48.39%) | 0.001 | 0.977 |
Years of education (Mean ± SD) a | 13.10 ± 3.40 | 12.99 ± 3.44 | 13.25 ± 3.34 | -0.39 | 0.696 |
Employed (N, %) b | 290(55.77%) | 171(56.44%) | 119(54.84%) | 0.13 | 0.718 |
Living with family (N, %) b | 478(91.92%) | 274(90.43%) | 204(94.01%) | 2.18 | 0.140 |
Comorbid substance abuse (N, %) b | 36(6.92%) | 18(5.94%) | 18(8.29%) | 1.09 | 0.297 |
Age of disease onset (N, %) b,c | 4.81 | 0.028 | |||
Early onset (≤ 25) | 250(48.08%) | 145(47.85%) | 125(57.60%) | ||
Late onset (> 25) | 270(51.92%) | 158(52.15%) | 92(42.40%) | ||
Duration of undiagnosed bipolar disorder (Month, Median and quartiles) a | 10(0.00, 54.19) | 12(0.00, 49.25) | 9.75(0.00, 64.50) | -0.14 | 0.888 |
Types of bipolar disorder | 49.69 | < 0.001 | |||
BD I (%) b | 399(76.73%) | 199(65.68%) | 200(92.17%) | ||
BD II (%) b | 121(23.27%) | 104(34.32%) | 17(7.83%) | ||
Duration of illness (Month, Median and quartiles)a | 45.00(13.00, 111.00) | 42.00(12.75, 93.50) | 48.00(13.00, 132.50) | -1.56 | 0.119 |
Polarity of first mood episode (N, %) b | 25.85 | < 0.001 | |||
Depressive | 307(59.04%) | 207(68.32%) | 100(46.08%) | ||
Manic/hypomanic/mixed | 213(40.96%) | 96(31.68%) | 117(53.92%) | ||
History of misdiagnosis | |||||
Major depressive disorder (N, %)a | 270(51.92%) | 193(63.70%) | 77(35.48%) | 40.32 | < 0.001 |
Schizophrenia (N, %)a | 89(17.12%) | 12(3.96%) | 77(35.48%) | 88.57 | < 0.001 |
Other mental disorders (N, %)a | 89(17.12%) | 44(14.52%) | 45(20.74%) | 3.44 | 0.063 |
Family history of mental disorders (N, %)b | 151(29.04%) | 91(30.03%) | 60(27.65%) | 0.35 | 0.555 |
History of psychiatric hospitalization (N, %)b | 415(79.81%) | 218(71.95%) | 197(90.78%) | 27.84 | < 0.001 |
Lifetime suicide behavior (N, %)b | 54(10.38%) | 28(9.24%) | 26(11.98%) | 1.02 | 0.312 |
Received drug treatment within the past 12 months | 487(93.65%) | 281(92.74%) | 206(94.93%) | 1.02 | 0.312 |
Antidepressants use (N, %)b | 160(30.77%) | 123(40.59%) | 37(17.05%) | 32.90 | < 0.001 |
Antipsychotics use (N, %)b | 392(75.38%) | 201(66.34%) | 191(88.02%) | 32.03 | < 0.001 |
Mood stabilizer use (N, %)b | 439(84.42%) | 246(81.19%) | 193(88.94%) | 5.78 | 0.016 |
Two or more mood stabilizers use (N, %)b | 119(22.88%) | 58(19.14%) | 61(28.11%) | 5.76 | 0.016 |
Received non-drug treatment within the past 12 months (N, %)b | 61(11.73%) | 33(10.89%) | 28(12.90%) | 0.49 | 0.482 |
Combined with chronic diseases requiring long-term treatment (N, %)b | 58(11.15%) | 29(9.57%) | 29(13.36%) | 1.84 | 0.175 |